Association between polycystic ovarian syndrome, overweight, and metabolic syndrome in adolescents

Journal of Pediatric and Adolescent Gynecology
Haleh RahmanpourKamran Azarkhish

Abstract

Polycystic syndrome (PCOS) is associated with multiple metabolic abnormalities. Studies in the adolescent population are still limited and the results have been much different. The aim of this study was to investigate the association between PCOS, overweight, and metabolic syndrome in adolescents. 30 PCOS adolescents were randomly selected from a PCOS population with NIH 1990 criteria and 71 adolescents from the normal adolescents. Anthropometric, hormonal and metabolic parameters were evaluated in four sub-groups including obese and non-obese PCOS and obese and non-obese normal adolescents. The prevalence of overweight and metabolic syndrome in adolescents with PCOS was 52% and 33.3% respectively vs 22.4% (P = 0.005) and 11.26% in control (normal) adolescents (P = 0.0001). Among all subjects, including obese and non-obese adolescents with or without PCOS, the prevalence of insulin resistance, hypercholesterolemia, central obesity, and metabolic syndrome was higher in obese PCOS with 61.5%, 46.2%, 53.8%, and 69.2%, respectively. Obesity and IR are important risk factors for metabolic syndrome in PCOS. Considering the long-term health risks, it is necessary to identify metabolic disorders in adolescents with PCOS as early as pos...Continue Reading

References

Jun 5, 1999·The American Journal of Cardiology·S M Grundy
Mar 3, 2001·American Journal of Obstetrics and Gynecology·S KorhonenS Saarikoski
Jan 16, 2002·JAMA : the Journal of the American Medical Association·Earl S FordWilliam H Dietz
Mar 13, 2002·The Journal of Clinical Endocrinology and Metabolism·Mark R PalmertAndrea Dunaif
Jun 8, 2004·The Journal of Clinical Endocrinology and Metabolism·Ricardo AzzizBulent O Yildiz
Jun 17, 2004·JAMA : the Journal of the American Medical Association·Allison A HedleyKatherine M Flegal
Sep 27, 2005·Lancet·K George M M AlbertiUNKNOWN IDF Epidemiology Task Force Consensus Group
Oct 4, 2006·Pediatrics·Martha Rodríguez-Morán, Fernando Guerrero-Romero
Feb 17, 2007·Clinical Obstetrics and Gynecology·Paulina A EssahJohn E Nestler
Jun 26, 2007·Lancet·Paul ZimmetUNKNOWN International Diabetes Federation Task Force on Epidemiology and Prevention of Diabetes
Jul 6, 2007·Diabetes Research and Clinical Practice·Hwi Ra ParkYeon-Ah Sung
Oct 11, 2007·The Journal of Clinical Endocrinology and Metabolism·Bulent O YildizRicardo Azziz
Nov 26, 2009·Best Practice & Research. Clinical Obstetrics & Gynaecology·Evanthia Diamanti-Kandarakis
Jun 12, 2010·Journal of Pediatric and Adolescent Gynecology·I T OzgenY Aliyazicıoglu
Nov 19, 2010·Reproductive Biology and Endocrinology : RB&E·Jia HuangDongzi Yang
Mar 26, 2011·Reproductive Biology and Endocrinology : RB&E·Fahimeh Ramezani TehraniFereidoun Azizi

❮ Previous
Next ❯

Citations

Nov 19, 2010·Reproductive Biology and Endocrinology : RB&E·Jia HuangDongzi Yang
Apr 16, 2013·Current Problems in Pediatric and Adolescent Health Care·Alvina R Kansra, Seema Menon
Jan 22, 2013·Orvosi hetilap·László Ságodi, László Barkai
Feb 20, 2013·Reproductive Biomedicine Online·Ning NingYulian Zhao
Sep 18, 2014·Fertility and Sterility·Michal YoungsterAmy D Divasta
Nov 16, 2014·Current Diabetes Reports·Anne-Marie Carreau, Jean-Patrice Baillargeon
Jan 6, 2015·Journal of Pediatric and Adolescent Gynecology·Sarah E PowersVeronica Gomez-Lobo
Aug 4, 2016·Journal of Pediatric and Adolescent Gynecology·Rashmi KudesiaStaci E Pollack
Oct 20, 2018·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·S S LimL J Moran
Aug 6, 2017·International Journal of Adolescent Medicine and Health·Mohammad H DabbaghmaneshHamidreza Tabatabaee
Sep 19, 2017·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·Seda AtesOsman Sevket
Sep 21, 2017·Clinical Endocrinology·Samira Behboudi-GandevaniFahimeh Ramezani Tehrani

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.